Correction of Anticoagulant Therapy in Patients with Severe COVID-19 Virus Infection Using a Thrombodynamics Coagulation Assay
Background The average frequency of thrombosis in patients with COVID-19 is still high despite low molecular weight heparin (LMWH) prophylactic. Global hemostasis assays, particularly thrombodynamics (TD), known to be sensitive to both hypercoagulation and heparin effects, could potentially be usefu...
Main Authors: | Tatiana S. Vuimo PhD, Sergey V. Tsarenko MD, Elena V. Filimonova PhD, Elena A. Seregina PhD, Sergey S. Karamzin PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-12-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296221142862 |
Similar Items
-
Effect of Anticoagulant Versus Non-Anticoagulant Therapy on Mortality
of Sepsis-Induced Disseminated
Intravascular Coagulation: A Systematic Review and Meta-Analysis
by: Wenqian Qi Ph.D, et al.
Published: (2023-02-01) -
Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants
by: Z. A. Gebekova, et al.
Published: (2022-11-01) -
Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis
by: Wenqian Qi PhD, et al.
Published: (2023-05-01) -
Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
by: Łukasz Pyka MD, PhD, et al.
Published: (2023-12-01) -
Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing
by: Bob Smit PhD, et al.
Published: (2023-06-01)